JP2004533246A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004533246A5 JP2004533246A5 JP2002587611A JP2002587611A JP2004533246A5 JP 2004533246 A5 JP2004533246 A5 JP 2004533246A5 JP 2002587611 A JP2002587611 A JP 2002587611A JP 2002587611 A JP2002587611 A JP 2002587611A JP 2004533246 A5 JP2004533246 A5 JP 2004533246A5
- Authority
- JP
- Japan
- Prior art keywords
- lactococcus
- strain
- gene
- transformed strain
- transformed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000178948 Lactococcus sp. Species 0.000 claims 11
- 108010022394 Threonine synthase Proteins 0.000 claims 3
- 230000003449 preventive effect Effects 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 230000009466 transformation Effects 0.000 claims 3
- 239000013612 plasmid Substances 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 102000003814 Interleukin-10 Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 241000194035 Lactococcus lactis Species 0.000 claims 1
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940076144 interleukin-10 Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01201631 | 2001-05-03 | ||
| EP01204785 | 2001-12-07 | ||
| PCT/EP2002/004942 WO2002090551A2 (en) | 2001-05-03 | 2002-05-03 | Self-containing lactococcus strain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008260591A Division JP2009060913A (ja) | 2001-05-03 | 2008-10-07 | 自己自制ラクトコッカス（Ｌｏｃｔｏｃｏｃｃｕｓ）株 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004533246A JP2004533246A (ja) | 2004-11-04 |
| JP2004533246A5 true JP2004533246A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4347575B2 JP4347575B2 (ja) | 2009-10-21 |
Family
ID=26076897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002587611A Expired - Fee Related JP4347575B2 (ja) | 2001-05-03 | 2002-05-03 | 自己自制ラクトコッカス（Ｌｏｃｔｏｃｏｃｃｕｓ）株 |
| JP2008260591A Withdrawn JP2009060913A (ja) | 2001-05-03 | 2008-10-07 | 自己自制ラクトコッカス（Ｌｏｃｔｏｃｏｃｃｕｓ）株 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008260591A Withdrawn JP2009060913A (ja) | 2001-05-03 | 2008-10-07 | 自己自制ラクトコッカス（Ｌｏｃｔｏｃｏｃｃｕｓ）株 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1383897B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4347575B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE331789T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002314040B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2446776C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60212825T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1383897T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2266515T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002090551A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780961B2 (en) | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
| JP2005529622A (ja) | 2002-06-19 | 2005-10-06 | ヴェーイーベー・ヴェーゼットウェー | 腸吸収を促進するための方法および手段 |
| WO2004056850A2 (en) * | 2002-12-19 | 2004-07-08 | Vib Vzw | Mutant proteins showing increased secretion |
| JP4589618B2 (ja) * | 2003-11-28 | 2010-12-01 | 独立行政法人農業生物資源研究所 | 免疫調節性機能を誘導する乳酸菌類とその成分 |
| US9200249B2 (en) | 2004-08-20 | 2015-12-01 | Actogenix N.V. | Method to improve Lactococcus preservation |
| US8748126B2 (en) * | 2005-11-29 | 2014-06-10 | Actogenix N.V. | Induction of mucosal tolerance to antigens |
| EP2097452A1 (en) * | 2006-12-14 | 2009-09-09 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| CN101605900B (zh) | 2007-01-12 | 2014-04-23 | 阿克图杰尼斯公司 | 乳球菌启动子和其用途 |
| EP2125010B1 (en) | 2007-01-25 | 2014-06-04 | Actogenix N.V. | Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| WO2010034844A1 (en) * | 2008-09-29 | 2010-04-01 | Actogenix N.V. | Reduced colonization of microbes at the mucosa |
| CA2837634C (en) | 2011-06-01 | 2021-12-14 | Actogenix Nv | Polycistronic expression system for bacteria |
| RU2653757C2 (ru) | 2011-09-23 | 2018-05-14 | Интрексон Актобиотикс Н.В. | Модифицированные грамположительные бактерии и их применение |
| ES2676707T3 (es) | 2011-09-23 | 2018-07-24 | Intrexon Actobiotics Nv | Bacterias gram positivas modificadas y usos de las mismas |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| RU2017130462A (ru) * | 2015-03-02 | 2019-04-02 | Синлоджик, Инк. | Бактерия, созданная для лечения заболеваний, облегчаемых при уменьшении воспаления кишечника и/или укреплении мукозного барьера кишечника |
| CN106148254B (zh) * | 2015-03-26 | 2019-11-12 | 南京华贞生物医药科技有限公司 | 一种用于减肥降脂的转化体及其构建方法与应用 |
| SG10202003100XA (en) | 2015-05-13 | 2020-05-28 | Synlogic Operating Co Inc | Bacteria Engineered to Reduce Hyperphenylalaninemia |
| US11685925B2 (en) | 2015-10-30 | 2023-06-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| ES2925049T3 (es) | 2015-11-16 | 2022-10-13 | Synlogic Operating Co Inc | Bacterias manipuladas para reducir la hiperfenilalaninemia |
| WO2017122180A1 (en) | 2016-01-14 | 2017-07-20 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
| CA3035151A1 (en) | 2016-09-02 | 2018-03-08 | Intrexon Actobiotics N.V. | Genetically modified bacteria stably expressing il-10 and insulin |
| IL265177B2 (en) | 2016-09-13 | 2025-01-01 | Intrexon Actobiotics N V | A microorganism that adheres to the mucosa |
| WO2020075171A1 (en) | 2018-10-11 | 2020-04-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Bacteria expressing single chain antibodies against toll-like receptors |
| CN114761028A (zh) | 2019-09-27 | 2022-07-15 | 英特瑞克斯顿阿克图比奥帝克斯有限公司 | 乳糜泻的治疗 |
| JP2023518184A (ja) | 2020-03-20 | 2023-04-28 | シンロジック オペレーティング カンパニー インコーポレイテッド | 高フェニルアラニン血症を軽減するように遺伝子改変された微生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4231764A1 (de) * | 1992-09-23 | 1994-03-24 | Inst Pflanzengenetik & Kultur | Verfahren zur chromosomalen Integration eines Produkt-Gens |
-
2002
- 2002-05-03 AU AU2002314040A patent/AU2002314040B2/en not_active Ceased
- 2002-05-03 DE DE60212825T patent/DE60212825T2/de not_active Expired - Lifetime
- 2002-05-03 ES ES02740565T patent/ES2266515T3/es not_active Expired - Lifetime
- 2002-05-03 AT AT02740565T patent/ATE331789T1/de active
- 2002-05-03 JP JP2002587611A patent/JP4347575B2/ja not_active Expired - Fee Related
- 2002-05-03 WO PCT/EP2002/004942 patent/WO2002090551A2/en not_active Ceased
- 2002-05-03 EP EP02740565A patent/EP1383897B1/en not_active Expired - Lifetime
- 2002-05-03 CA CA2446776A patent/CA2446776C/en not_active Expired - Fee Related
- 2002-05-03 DK DK02740565T patent/DK1383897T3/da active
-
2008
- 2008-10-07 JP JP2008260591A patent/JP2009060913A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004533246A5 (cg-RX-API-DMAC7.html) | ||
| CA2446776A1 (en) | Self-containing lactococcus strain | |
| CN102906105B (zh) | 肽及其用途 | |
| JP2003531157A5 (cg-RX-API-DMAC7.html) | ||
| KR20250114110A (ko) | 약물 활성의 조절제로서의 부프로피온 | |
| JP2007526248A5 (cg-RX-API-DMAC7.html) | ||
| WO2008101907A3 (en) | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase | |
| WO2007009539A3 (en) | Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases | |
| WO2007144394A3 (en) | Pharmaceutical use of substituted piperidine carboxamides | |
| CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
| EP1529527A3 (en) | Valproic acid for a combination treatment of human cancers, tumor metastasis and minimal residual disease | |
| JP2011524850A5 (cg-RX-API-DMAC7.html) | ||
| JP2004510493A5 (cg-RX-API-DMAC7.html) | ||
| MX2009008228A (es) | N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide. | |
| JP2010500399A5 (cg-RX-API-DMAC7.html) | ||
| BR0206689A (pt) | Combinação de probióticos, e, uso desta | |
| JP2020193206A5 (cg-RX-API-DMAC7.html) | ||
| JP2011225596A5 (cg-RX-API-DMAC7.html) | ||
| JP2008541759A5 (cg-RX-API-DMAC7.html) | ||
| JP2017222722A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508338A5 (cg-RX-API-DMAC7.html) | ||
| JP2009535328A5 (cg-RX-API-DMAC7.html) | ||
| AU2002359162A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
| JP2008538288A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508872A5 (cg-RX-API-DMAC7.html) |